• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

10040 例白癜风非同期队列患者中黑色素瘤和非黑色素瘤皮肤癌发病率明显降低。

Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo.

机构信息

Health Services Research Unit, Istituto Dermopatico dell'Immacolata, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy.

Health Services Research Unit, Istituto Dermopatico dell'Immacolata, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy.

出版信息

J Am Acad Dermatol. 2014 Dec;71(6):1110-6. doi: 10.1016/j.jaad.2014.07.050. Epub 2014 Sep 19.

DOI:10.1016/j.jaad.2014.07.050
PMID:25242557
Abstract

BACKGROUND

Genetic findings suggesting a lower susceptibility to melanoma in patients with vitiligo are supported by recent clinical studies. Nonmelanoma skin cancer (NMSC) has also been studied, but mainly in small samples, and with conflicting results.

OBJECTIVE

We sought to study the relative risk (RR) of melanoma and NMSC in patients with vitiligo compared with that in patients seen for vascular surgery.

METHODS

The frequency of melanoma and NMSC was compared between patients with vitiligo and patients seen for vascular surgery. Occurrence of skin cancer was compared by computing RR and modeled using multiple logistic regression.

RESULTS

Overall, the crude RR for melanoma was 0.24 (95% confidence interval [CI] 0.13-0.45) in patients with vitiligo compared with those with a nondermatologic condition (occurrence 1.1‰, 95% CI 0.5‰-2.0‰ in patients with vitiligo and occurrence 4.5‰, 95% CI 3.8‰-5.4‰ in the control cohort). The crude RR for NMSC was 0.19 (95% CI 0.14-0.17) and the occurrence was 3.8‰ (95% CI 2.7‰-5.2‰) among patients with vitiligo and 19.6‰ (95% CI 18.0‰-21.4‰) in control subjects. Patients with vitiligo who underwent phototherapy had a markedly higher risk of both cancers.

CONCLUSIONS

In our large study, patients with vitiligo have a decreased risk of developing skin neoplasms, even considering that a larger proportion in this patient group is exposed to higher levels of ultraviolet radiation.

摘要

背景

遗传研究发现,白癜风患者罹患黑色素瘤的风险较低,这一结果得到了近期临床研究的支持。非黑素瘤皮肤癌(NMSC)也有相关研究,但主要集中在小样本中,且结果相互矛盾。

目的

我们旨在研究白癜风患者罹患黑色素瘤和 NMSC 的相对风险(RR)与血管外科患者的风险相比。

方法

比较白癜风患者和血管外科患者的黑色素瘤和 NMSC 发生率。通过计算 RR 并使用多因素逻辑回归模型来比较皮肤癌的发生情况。

结果

总体而言,与非皮肤科疾病患者相比,白癜风患者罹患黑色素瘤的粗 RR 为 0.24(95%置信区间 [CI] 0.13-0.45)(白癜风患者中黑色素瘤的发生率为 1.1‰,95%CI 0.5‰-2.0‰,对照组中的发生率为 4.5‰,95%CI 3.8‰-5.4‰)。NMSC 的粗 RR 为 0.19(95% CI 0.14-0.17),发生率为 3.8‰(95% CI 2.7‰-5.2‰),而对照组中的发生率为 19.6‰(95% CI 18.0‰-21.4‰)。接受光疗的白癜风患者罹患这两种癌症的风险明显更高。

结论

在我们的大型研究中,即使考虑到该患者群体中更多的人暴露于更高水平的紫外线辐射,白癜风患者罹患皮肤肿瘤的风险也较低。

相似文献

1
Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo.10040 例白癜风非同期队列患者中黑色素瘤和非黑色素瘤皮肤癌发病率明显降低。
J Am Acad Dermatol. 2014 Dec;71(6):1110-6. doi: 10.1016/j.jaad.2014.07.050. Epub 2014 Sep 19.
2
Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners.白癜风患者罹患黑素瘤和非黑素瘤皮肤癌风险降低:对 1307 名患者及其伴侣的调查。
Br J Dermatol. 2013 Jan;168(1):162-71. doi: 10.1111/bjd.12111.
3
Skin Cancer Risk (Nonmelanoma Skin Cancers/Melanoma) in Vitiligo Patients.白癜风患者的皮肤癌风险(非黑色素瘤皮肤癌/黑色素瘤)
Dermatol Clin. 2017 Apr;35(2):129-134. doi: 10.1016/j.det.2016.11.003.
4
Reduced frequency of non-melanoma skin cancer in 72,739 patients with psoriasis: a retrospective study.72739例银屑病患者非黑色素瘤皮肤癌发病率降低:一项回顾性研究
Eur J Dermatol. 2017 Aug 1;27(4):359-362. doi: 10.1684/ejd.2017.3032.
5
Risk of skin cancer in patients with pterygium: a nationwide population-based cohort study in Taiwan.翼状胬肉患者皮肤癌的风险:台湾全国基于人群的队列研究。
Ocul Surf. 2014 Jan;12(1):69-76. doi: 10.1016/j.jtos.2013.08.003. Epub 2013 Oct 18.
6
Risk of Melanoma and Nonmelanoma Skin Cancer in People with Vitiligo: United Kingdom Population-Based Cohort Study.白癜风患者罹患黑素瘤和非黑素瘤皮肤癌的风险:英国基于人群的队列研究。
J Invest Dermatol. 2023 Nov;143(11):2204-2210. doi: 10.1016/j.jid.2023.04.013. Epub 2023 May 3.
7
Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease.接受硫唑嘌呤治疗炎症性肠病的患者发生非黑素瘤皮肤癌的风险增加。
Gastroenterology. 2011 Nov;141(5):1621-28.e1-5. doi: 10.1053/j.gastro.2011.06.050. Epub 2011 Jun 25.
8
Association between dietary fat and skin cancer in an Australian population using case-control and cohort study designs.采用病例对照研究和队列研究设计,对澳大利亚人群中膳食脂肪与皮肤癌之间的关联进行研究。
BMC Cancer. 2006 May 30;6:141. doi: 10.1186/1471-2407-6-141.
9
The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population-based matched cohort study in Korea.白癜风患者中黑色素瘤和非黑色素瘤皮肤癌的发病率及生存率:韩国一项基于全国人群的配对队列研究
Br J Dermatol. 2020 Apr;182(4):907-915. doi: 10.1111/bjd.18247. Epub 2019 Sep 18.
10
In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis.体外对中波紫外线的敏感性与皮肤癌风险:一项病例对照分析。
J Natl Cancer Inst. 2005 Dec 21;97(24):1822-31. doi: 10.1093/jnci/dji429.

引用本文的文献

1
Multi-Omics Integration with Machine Learning and Molecular Docking Reveals Crosstalk Mechanisms and Drug Candidates in Metastatic Melanoma and Vitiligo.多组学与机器学习及分子对接相结合揭示转移性黑色素瘤和白癜风中的串扰机制及候选药物。
Clin Cosmet Investig Dermatol. 2025 Aug 29;18:2047-2066. doi: 10.2147/CCID.S533281. eCollection 2025.
2
Cancer Risk in Vitiligo: No Evidence of Increased Prevalence-A Systematic Review and Meta-analysis.白癜风患者的癌症风险:无患病率增加的证据——一项系统评价与荟萃分析
Dermatol Ther (Heidelb). 2025 Aug 18. doi: 10.1007/s13555-025-01520-0.
3
Vitiligo.
白癜风
J Dtsch Dermatol Ges. 2025 Aug;23(8):968-987. doi: 10.1111/ddg.15706.
4
Metabolic anomalies in vitiligo: a new frontier for drug repurposing strategies.白癜风的代谢异常:药物再利用策略的新前沿。
Front Pharmacol. 2025 Apr 15;16:1546836. doi: 10.3389/fphar.2025.1546836. eCollection 2025.
5
The glycoprotein GPNMB protects against oxidative stress through enhanced PI3K/AKT signaling in epidermal keratinocytes.糖蛋白GPNMB通过增强表皮角质形成细胞中的PI3K/AKT信号传导来抵御氧化应激。
J Biol Chem. 2025 Mar;301(3):108299. doi: 10.1016/j.jbc.2025.108299. Epub 2025 Feb 11.
6
Recent clinical and mechanistic insights into vitiligo offer new treatment options for cell-specific autoimmunity.近期对白癜风的临床和机制研究为细胞特异性自身免疫提供了新的治疗选择。
J Clin Invest. 2025 Jan 16;135(2):e185785. doi: 10.1172/JCI185785.
7
The many faces of autoimmune-mediated melanocyte destruction in melanoma.自身免疫介导的黑色素瘤黑素细胞破坏的多面性。
Front Immunol. 2024 Oct 3;15:1417273. doi: 10.3389/fimmu.2024.1417273. eCollection 2024.
8
Anti-tumor immunity and vitiligo: from immune-related adverse reactions to protection from cancer.抗肿瘤免疫与白癜风:从免疫相关不良反应到癌症防护
Immunotherapy. 2024;16(13):841-843. doi: 10.1080/1750743X.2024.2377954. Epub 2024 Jul 26.
9
Perception of skin cancer risk and sun protective practices in individuals with vitiligo: a prospective international cross-sectional survey.白癜风患者对皮肤癌风险的认知和防晒行为:一项前瞻性国际横断面调查。
Arch Dermatol Res. 2024 May 22;316(5):189. doi: 10.1007/s00403-024-02942-0.
10
Vitiligo-like Lesions as a Predictor of Response to Immunotherapy in Non-Small Cell Lung Cancer: Comprehensive Review and Case Series from a University Center.白癜风样病变作为非小细胞肺癌免疫治疗反应的预测因子:来自大学中心的全面回顾和病例系列。
Curr Oncol. 2024 Feb 19;31(2):1113-1128. doi: 10.3390/curroncol31020083.